Nicholas Rossettos
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Nicholas Rossettos
Earlier roles on record: CFO at Tempest Therapeutics, Inc. (TPST) until September 22, 2026. Tempest Therapeutics, Inc. reported in an 8-K filed September 28, 2026 that Nicholas Rossettos resigned as Chief Financial Officer, effective September 22, 2026. Tempest Therapeutics, Inc. reported in an 8-K filed August 24, 2026 that Nicholas Rossettos was appointed Chief Financial Officer Principal Financial and Accounting Officer, Treasurer, and Corporate Secretary, effective September 1, 2026.
“On September 22, 2026, Mr. Nicholas Rossettos confirmed to Tempest Therapeutics, Inc. (the “Company”) that he would be resigning from his position as Chief Financial Officer of the Company and from any and all other positions he holds with the Company, effective immediately.”
“Effective September 1, 2026, the Board of Directors of the Company (the “Board”) appointed Mr. Nicholas Rossettos as Chief Financial Officer Principal Financial and Accounting Officer, Treasurer, and Corporate Secretary of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2026-09-01–2026-09-22
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.